Médecine

Paramédical

Autres domaines


S'abonner

An update on the pathophysiology of osteoarthritis - 03/01/17

Doi : 10.1016/j.rehab.2016.07.004 
Ali Mobasheri a, b, c, d, e, f, , Mark Batt c
a Department of Veterinary Pre-Clinical Sciences, School of Veterinary Medicine, University of Surrey, Guildford GU2 7AL, United Kingdom 
b Faculty of Health and Medical Sciences, Duke of Kent Building, University of Surrey, Guildford, Surrey GU2 7XH, United Kingdom 
c Arthritis Research UK Centre for Sport, Exercise and Osteoarthritis, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom 
d Arthritis Research UK Pain Centre, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom 
e Medical Research Council and Arthritis Research UK Centre for Musculoskeletal Ageing Research, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom 
f Center of Excellence in Genomic Medicine Research (CEGMR), King Fahd Medical Research Center (KFMRC), Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia 

Corresponding author at: Department of Veterinary Pre-Clinical Sciences, School of Veterinary Medicine, University of Surrey, Guildford GU2 7AL, United Kingdom.Department of Veterinary Pre-Clinical Sciences, School of Veterinary Medicine, University of SurreyGuildford GU2 7ALUnited Kingdom

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Introduction

Osteoarthritis (OA) is one of the most common forms of arthritis. There is accumulating evidence to suggest that OA is an inflammatory disease of the entire synovial joint and has multiple phenotypes. This presents the OA research community with new challenges and opportunities. The main challenge is to understand the root cause of the disease and identify differences and similarities between OA phenotypes. The key opportunity is the possibility of developing personalized and individualized prevention and treatment strategies for OA patients with different phenotypes of the disease. Indeed, it has been suggested that this is the era of ‘personalized prevention’ for OA. The aim of this mini-review paper is to focus on the pathophysiological aspects of OA development and progression, review the current concepts and discuss the future of personalized medicine for OA.

Method

The PubMed/MEDLINE bibliographic database was searched using the keywords ‘pathophysiology’ and ‘osteoarthritis’.

Results

The PubMed/MEDLINE search yielded more than 12,000 relevant papers. A selection of these papers is reviewed here.

Conclusion

There has been slow but steady progress in our understanding of the pathophysiology of OA over the last two decades. However, large gaps remain in our knowledge of OA pathogenesis and this impacts negatively on patients and drug development pipeline. In the absence of new pharmaceutical agents and disease modifying osteoarthritis drugs (DMOADs) it is clear that lifestyle modification and physical activity are important and may delay the need for surgical intervention.

Le texte complet de cet article est disponible en PDF.

Keywords : Synovial joint, Articular cartilage, Synovium, Osteoarthritis (OA), Pathophysiology, Physical Activity, Physical Rehabilitation


Plan


© 2016  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 59 - N° 5-6

P. 333-339 - décembre 2016 Retour au numéro
Article précédent Article précédent
  • Superficial warming and cooling of the leg affects walking speed and neuromuscular impairments in people with spastic paraparesis
  • A. Denton, L. Bunn, A. Hough, G. Bugmann, J. Marsden
| Article suivant Article suivant
  • Takotsubo cardiomyopathy as a reversible complication of intrathecal baclofen withdrawal
  • Jonathan Levy, Gratiane De Brier, Caroline Hugeron, Thibaud Lansaman, Djamel Bensmail

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

;

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.